Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide

Neuropeptides

Volumn 37, Issue 6, 2003, Pages 362-368

  Arlt, Josef ^a   Jahn, Holger ^a   Kellner, Michael ^a   Ströhle, Andreas ^b   Yassouridis, Alexander ^b   Wiedemann, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Atrial natriuretic peptide; Autonomous nervous system; Corticotropin releasing hormone; Heart rate variability; Hypothalamic pituitary adrenocortical system; LF HF ratio; Total power

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN RELEASING FACTOR;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FREQUENCY MODULATION; HEART RATE VARIABILITY; HORMONE ACTION; HUMAN; INFUSION; MALE; NEUROMODULATION; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE; VAGUS NERVE STIMULATION;

EID: 0346494949     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2003.09.006     Document Type: Article

References (40)

1. Akselrod, S., Gordon, D., Ubel, F.A., Shannon, D.C., Berger, A.C., Cohen, R.J., 1981. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213, 220-222.
2. Antoni, F.A., Hunter, E.F., Lowry, P.J., Noble, J.M., Seckl, J.R., 1992. Atriopeptin: an endogenous corticotropin-release inhibiting hormone. Endocrinology 130, 1753-1755.
3. Berntson, G.G., Bigger Jr., J.T., Eckberg, D.L., Grossman, P., Kaufmann, P.G., Malik, M., Nagaraja, H.N., Porges, S.W., Saul, J.P., Stone, P.H., van der Molen, M.W., 1997. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 34, 623-648.
4. Bierwolf, C., Burgemeister, A., Luthke, K., Born, J., Fehm, H.L., 1998. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men. J. Clin. Endocrinol. Metab. 83, 1151-1157.
5. Butler, G.C., Senn, B.L., Floras, J.S., 1994. Influence of atrial natriuretic factor on heart rate variability in normal men. Am. J. Physiol. 267, H500-505.
6. Cerutti, S., Bianchi, A.M., Mainardi, L.T., 1995. Spectral Analysis of the Heart Rate Variability Signal. Heart Rate Variability. Futura Publishing Inc, Armonk, NY, pp. 63-74.
7. Curtis, A.L., Lechner, S.M., Pavcovich, L.A., Valentine, R.J., 1997. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281, 163-172.
8. Dayanithi, G., Antoni, F.A., 1990. Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase. J. Endocrinol. 125, 39-44.
9. Deuschle, M., Lederbogen, F., 2002. Depression and cardiovascular disease: pathogenetic factors of the stress concept. Fortschr. Neurol. Psychiatr. 70, 268-275.
10. Fink, G., Dow, R.C., Casley, D., Johnston, C.I., Lim, A.T., Copolov, D.L., Bennie, J., Carroll, S., Dick, H., 1991. Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. J. Endocrinol. 131, R9-R12.
11. Holsboer, F., 2001. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62, 77-91.
12. Jessop, D.S., 1999. Review: central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J. Endocrinol. 160, 169-180.
13. Jiao, J.H., Baertschi, A.J., 1993. Neural control of the endocrine rat heart. Proc. Natl. Acad. Sci. USA 90, 7799-7803.
14. Kamath, M.V., Fallen, E.L., 1993. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit. Rev. Biomed. Eng. 21, 245-311.
15. Kellner, M., Herzog, L., Yassouridis, A., Holsboer, F., Wiedemann, K., 1995. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am. J. Psychiatry 152, 1365-1367.
16. Kellner, M., Wiedemann, K., Holsboer, F., 1992. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci. 50, 1835-1842.
17. Lim, A.T., Dow, R.C., Yang, Z., Fink, G., 1994. ANP(5-28) is the major molecular species in hypophysial portal blood of the rat. Peptides 15, 1557-1559.
18. Maack, T., 1995. Receptors of Natriuretic Peptides: Structure, Function and Regulation. Raven Press, New York.
19. Malik, M., Bigger, J.T., Camm, A.J., Kleiger, R.E., Malliani, A., Moss, A.J., Schwartz, P.J., Breithardt, G., Cerutti, S., Cohen, R.J., Coumel, P., Fallen, E.L., Kennedy, H.L., Lombardi, F., Rottman, J.N., Schmidt, G., Singer, D.H., 1996. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043-1065.
20. Malliani, A., Lombardi, F., Pagani, M., 1994. Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br. Heart J. 71, 1-2.
21. Malliani, A., Pagani, M., Lombardi, F., Cerutti, S., 1991. Cardiovascular neural regulation explored in the frequency domain. Circulation 84, 482-492.
22. Montano, N., Ruscone, T.G., Porta, A., Lombardi, F., Pagani, M., Malliani, A., 1994. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 90, 1826-1831.
23. Nijsen, M.J., Croiset, G., Diamant, M., Stam, R., Kamphuis, P.J., Bruijnzeel, A., de Wied, D., Wiegant, V.M., 2000a. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat. Eur. J. Pharmacol. 389, 89-98.
24. Nijsen, M.J., Croiset, G., Stam, R., Bruijnzeel, A., Diamant, M., de Wied, D., Wiegant, V.M., 2000b. The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neuropsychopharmacology 22, 388-399.
25. Overton, J.M., Fisher, L.A., 1991. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats. J. Auton. Nerv. Syst. 35, 43-51.
26. Pagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P., Sandrone, G., Malfatto, G., Dell'Orto, S., Piccaluga, E., 1986. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ. Res. 59, 178-193.
27. Pomeranz, B., Macaulay, R.J., Caudill, M.A., Kutz, I., Adam, D., Gordon, D., Kilborn, K.M., Barger, A.C., Shannon, D.C., Cohen, R.J., et al., 1985. Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 248, H151-H153.
28. Rimoldi, O., Pierini, S., Ferrari, A., Cerutti, S., Pagani, M., Malliani, A., 1990. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am. J. Physiol. 258, H967-H976.
29. Rosenzweig, A., Seidman, C.E., 1991. Atrial natriuretic factor and related pepticle hormones. Annu. Rev. Biochem. 60, 229-255.
30. Sakanaka, M., Shibasaki, T., Lederis, K., 1986. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382, 213-238.
31. Seier, F.E., Kellner, M., Yassouridis, A., Heese, R., Strian, F., Wiedemann, K., 1997. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks. Am. J. Physiol. 272, H2630-H2638.
32. Steiger, A., Holsboer, F., 1997. Neuropeptides and human sleep. Sleep 20, 1038-1052.
33. Stiedl, O., Meyer, M., 2003. Cardiac dynamics in corticotropin-releasing factor receptor subtype-2 deficient mice. Neuropeptides 37, 3-16.
34. Tanaka, I., Inagami, T., 1986. Release of immunoreactive atrial natriuretic factor from rat hypothalamus in vitro. Eur. J. Pharmacol. 122, 353-355.
35. Taylor, J.A., Carr, D.L., Myers, C.W., Eckberg, D.L., 1998. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation 98, 547-555.
36. Thompson, J.S., Morice, A.H., 1996. Neutral endopeptidase inhibitors and the pulmonary circulation. Gen. Pharmacol. 27, 581-585.
37. Valentino, R.J., Page, M., Van Bockstaele, E., Aston-Jones, G., 1992. Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience 48, 689-705.
38. Wiedemann, K., Jahn, H., Kellner, M., 2000. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp. Clin. Endocrinol. Diabetes 108, 5-13.
39. Wiedemann, K., Jahn, H., Yassouridis, A., Kellner, M., 2001. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks - preliminary findings. Arch. Gen. Psychiatry 58, 371-377.
40. Wiersma, A., Bohus, B., Koolhaas, J.M., 1993. Corticotropin-releasing hormone microinfusion in the central amygdala diminishes a cardiac parasympathetic outflow under stress-free conditions. Brain Res. 625, 219-227.